Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 10 of 13 found articles
 
 
  Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
 
 
Title: Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Author: Schneider, Lon S.
Kennedy, Richard E.
Cutter, Gary R.
Appeared in: Alzheimer's & dementia
Paging: Volume 6 (2010) nr. 5 pages 11 p.
Year: 2010
Contents:
Publisher: The Alzheimer's Association
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 10 of 13 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands